Photo by lamoune from unsplash
The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection since December 2019 has provided clinicians with a battery of laboratory tests and imaging tools to back up in… Click to show full abstract
The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection since December 2019 has provided clinicians with a battery of laboratory tests and imaging tools to back up in the speedy pin-pointing of high-risk COVID-19 victims, enabling them to make the most optimized treatments for COVID-19 patients lowering the mortality rates. The biochemical tests include inflammatory markers, hematological parameters, liver and kidney functions. © 2022. Yusof and Haque. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Journal Title: Journal of Applied Pharmaceutical Science
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!